首页> 外文期刊>Central European Journal of Biology >Inhibition of lncRNA LINC00461/miR-216a/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma
【24h】

Inhibition of lncRNA LINC00461/miR-216a/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma

机译:LNCRNA LINC00461 / miR-216a / aquaporin 4途径的抑制抑制了胶质瘤中的细胞增殖,迁移,侵袭和化学抑制

获取原文
       

摘要

Long noncoding RNA (lncRNA) LINC00461 (LINC00461) is reported to be related to glioma progression. However, the mechanism of LINC00461 in glioma remains unclear. Expression of LINC00461, miRNA (miR)-216a, and aquaporin 4 (AQP4) was detected using real-time quantitative PCR (RT-qPCR) and western blotting. Proliferation, temozolomide (TMZ) resistance, migration, and invasion were assessed by MTT, colony formation, and transwell assays, respectively. The target binding among miR-216a, LINC00461, and AQP4 was confirmed by the luciferase reporter assay. The tumor growth was monitored in the xenograft experiment. LINC00461 was upregulated, and miR-216a was downregulated in glioma tissues and cells, and LINC00461 upregulation was correlated with large tumor size, higher WHO grade and recurrence, and poor overall survival. LINC00461 knockdown suppressed cell viability, abilities of cell cloning and migration and invasion, and TMZ resistance in glioma. Mechanically, LINC00461 was confirmed to sponge miR-216a to affect AQP4 expression. Rescue assays verified that miR-216a downregulation or AQP4 upregulation abrogated the inhibitory effect of LINC00461 knockdown on cell proliferation, migration, invasion, and TMZ resistance in vitro . Moreover, LINC00461 downregulation blocked the glioma tumor growth in vivo. In conclusion, LINC00461 knockdown inhibits glioma cell proliferation, migration, invasion, and TMZ resistance through miR-216a/AQP4 axis, suggesting LINC00461 as an oncogene in glioma progression.
机译:据报道,长度非致RNA(LNCRNA)LINC00461(LINC00461)与胶质瘤进展有关。然而,LINC00461在胶质瘤中的机制尚不清楚。使用实时定量PCR(RT-QPCR)和Western印迹检测LINC00461,miRNA(miR)-216a和aquaporin 4(aqp4)的表达。通过MTT,菌落形成和Transwell测定分别评估增殖,替替唑胺(TMZ)抗性,迁移和侵袭。 MiR-216A,LINC00461和AQP4之间的靶结合被荧光素酶报告结果证实。在异种移植实验中监测肿瘤生长。上调LINC00461,MiR-216a在胶质瘤组织和细胞中下调,升级与大肿瘤大小相关,较高的人级和复发,整体存活差。 LINC00461击倒抑制抑制细胞活力,细胞克隆和迁移和侵袭的能力和胶质瘤中的TMZ抗性。机械地,确认LINC00461将MIR-216A海绵状,以影响AQP4表达。救援分析证实,MIR-216A下调或AQP4上调废除了LINC00461敲低对细胞增殖,迁移,侵袭和TMZ抗性的抑制作用。此外,LINC00461下调阻断了体内胶质瘤肿瘤生长。总之,LINC00461通过miR-216a / aqp4轴敲低抑制胶质瘤细胞增殖,迁移,侵袭和tmz抗性,表明LINC00461作为胶质瘤进展中的癌基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号